Clinical Trial Update: Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) [Phase 3]

View source ↗

Summary

Phase 3 trial updating the efficacy and safety comparison between a calcineurin inhibitor (CNI) and a CNI-free regimen in renal transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Failure
• Renal Transplant

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Kidney Failure | Phase 3 | Status: UNKNOWN